Zobrazeno 1 - 10
of 240
pro vyhledávání: '"Stefan Rieken"'
Autor:
Martin Leu, Hanibal Bohnenberger, Manuel Guhlich, Markus Anton Schirmer, Yiannis Pilavakis, Hendrik Andreas Wolff, Stefan Rieken, Leif Hendrik Dröge
Publikováno v:
Cancer Reports, Vol 7, Iss 8, Pp n/a-n/a (2024)
Abstract Background and Aim The German NPC‐GPOH trials introduced treatment including neoadjuvant chemotherapy, radiochemotherapy (RCT) and antiviral treatment in patients aged 25 years or younger with nasopharyngeal cancer (NPC). We conducted a re
Externí odkaz:
https://doaj.org/article/212756e107064bf7a509eb55d7510d11
Autor:
Manuel Guhlich, Teresa Esther Maag, Leif Hendrik Dröge, Andrea Hille, Sandra Donath, Stephanie Bendrich, Markus Anton Schirmer, Friedemann Nauck, Martin Leu, Joachim Riggert, Julia Gallwas, Stefan Rieken
Publikováno v:
Radiation Oncology, Vol 18, Iss 1, Pp 1-11 (2023)
Abstract Background Significant bleeding of tumor sites is a dreaded complication in oncological diseases and often results in clinical emergencies. Besides basic local and interventional procedures, an urgent radiotherapeutic approach can either ach
Externí odkaz:
https://doaj.org/article/6a8fb19457a04247874ea13188981cb2
Autor:
Christoph A. Fink, Fabian Weykamp, Sebastian Adeberg, Farastuk Bozorgmehr, Petros Christopoulos, Kristin Lang, Laila König, Juliane Hörner-Rieber, Michael Thomas, Martin Steins, Rami A. El-Shafie, Stefan Rieken, Denise Bernhardt, Jürgen Debus
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 42, Iss , Pp 100665- (2023)
Background: Combined, platinum-based thoracic chemoradiotherapy (TCR) is the current state-of-the-art treatment for patients with limited disease (LD) small-cell lung cancer (SCLC). There is only limited data available regarding the effect of comorbi
Externí odkaz:
https://doaj.org/article/9f830e93156f4ac5b00009d11a666d5a
Autor:
Farastuk Bozorgmehr, Petros Christopoulos, Inn Chung, Jelena Cvetkovic, Manuel Feißt, Johannes Krisam, Marc A. Schneider, Claus Peter Heußel, Michael Kreuter, Daniel W. Müller, Michael Thomas, Stefan Rieken
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-9 (2022)
Abstract Background Recently, the combination of the programmed death-ligand 1 (PD-L1) inhibitor atezolizumab with first-line chemotherapy has demonstrated to improve outcome for patients with advanced small cell lung cancer (SCLC), leading to approv
Externí odkaz:
https://doaj.org/article/7e030e52fb5146e9b61643c7598ec3bd
Autor:
Friederike Braulke, Kathrin Kober, Andreas Arndt, Maximilian Papendick, Arne Strauss, Christof Maria Kramm, Kai-Martin Thoms, Alexander König, Jochen Gaedcke, Julia Gallwas, Svenja Wulf, Christoph Szuszies, Gerald Wulf, Ralph Rödel, Susanne Wolfer, Vesna Malinova, Tobias R. Overbeck, Marc Hinterthaner, Joachim Lotz, Friedemann Nauck, Marielle Ernst, Christine Stadelmann, Philipp Ströbel, Volker Ellenrieder, Thomas Asendorf, Stefan Rieken
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
IntroductionMulti-professional interdisciplinary tumor boards (ITB) are essential institutions to discuss all newly diagnosed, relapsed or complex cancer patients in a team of specialists to find an optimal cancer care plan for each individual patien
Externí odkaz:
https://doaj.org/article/d89f4a014aa445bd8cdf487b1b57a9f6
Autor:
Felix-Nikolai Oschinka Jegor Habermann, Daniela Schmitt, Thomas Failing, Jann Fischer, David Alexander Ziegler, Laura Anna Fischer, Niklas Josua Alt, Julian Muster, Sandra Donath, Andrea Hille, Markus Anton Schirmer, Manuel Guhlich, Rami A. El Shafie, Stefan Rieken, Martin Leu, Leif Hendrik Dröge
Publikováno v:
Current Oncology, Vol 29, Iss 2, Pp 1080-1092 (2022)
The pandemic raised a discussion about the postponement of medical interventions for non-small cell lung cancer (NSCLC). We analyzed the characteristics of pretreatment diagnostic assessment in the pandemic and the influence of diagnostic assessment
Externí odkaz:
https://doaj.org/article/3a9b6fdc45e7420d9b355a24d800df48
Autor:
Tanja Eichkorn, Jonathan W. Lischalk, Cedric Stüwe, Eric Tonndorf-Martini, Kai Schubert, Lisa-Antonia Dinges, Sebastian Regnery, Farastuk Bozorgmehr, Laila König, Petros Christopoulos, Juliane Hörner-Rieber, Sebastian Adeberg, Klaus Herfarth, Hauke Winter, Michael Thomas, Stefan Rieken, Jürgen Debus, Rami A. El Shafie
Publikováno v:
Frontiers in Oncology, Vol 12 (2023)
IntroductionA very narrow therapeutic window exists when delivering curative chemoradiotherapy for inoperable locally advanced non-small cell lung cancer (NSCLC), particularly when large distances exist between areas of gross disease in the thorax. I
Externí odkaz:
https://doaj.org/article/37743337ff4c4493a6bda50b5b332b61
Autor:
Farastuk Bozorgmehr, Inn Chung, Petros Christopoulos, Johannes Krisam, Marc A. Schneider, Lena Brückner, Daniel Wilhelm Mueller, Michael Thomas, Stefan Rieken
Publikováno v:
BMC Cancer, Vol 23, Iss 1, Pp 1-1 (2023)
Externí odkaz:
https://doaj.org/article/5127c969646443f1add3597e420188ff
Autor:
Laura Hartmann, Philipp Schröter, Wolfram Osen, Daniel Baumann, Rienk Offringa, Mahmoud Moustafa, Rainer Will, Jürgen Debus, Stephan Brons, Stefan Rieken, Stefan B. Eichmüller
Publikováno v:
Scientific Reports, Vol 10, Iss 1, Pp 1-13 (2020)
Abstract While for photon radiation hypofractionation has been reported to induce enhanced immunomodulatory effects, little is known about the immunomodulatory potential of carbon ion radiotherapy (CIRT). We thus compared the radio-immunogenic effect
Externí odkaz:
https://doaj.org/article/922b225c3b544655b294c9222875593d
Autor:
Farastuk Bozorgmehr, Inn Chung, Petros Christopoulos, Johannes Krisam, Marc A. Schneider, Lena Brückner, Daniel Wilhelm Mueller, Michael Thomas, Stefan Rieken
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-10 (2020)
Abstract Background Non-small cell lung cancer is the most common cause of cancer death worldwide, highlighting the need for novel therapeutic concepts. In particular, there is still a lack of treatment strategies for the group of elderly and frail p
Externí odkaz:
https://doaj.org/article/6ee57f5784934692abfb91344ca3fbd7